Phamatech, Inc.

Click Here To EMAIL INQUIRY
Web: http://www.phamatech.com
E-Mail:
Address: 10151 Barnes Canyon Rd., San Diego, California 92121, USA
Phone: +1-(858)-643-5555 | Fax: +1-(858)-635-5843 | Map/Directions >>

Profile: Phamatech, Inc. manufactures products and renders services that enhance medical care, health awareness and quality of life by aiding in the early diagnosis of medical conditions. We have FDA-clearance on the United States first over-the-counter drug. We provide abuse test kits, pregnancy test kits and OTC cleared test kits.

21 Products/Services (Click for related suppliers)

• Amphetamine Enzyme Immunoassay Test (FDA Code: DKZ / 862.3100)

An amphetamine test system is a device intended to measure amphetamine, a central nervous system stimulating drug, in plasma and urine. Measurements obtained by this device are used in the diagnosis and treatment of amphetamine use or overdose and in monitoring levels of amphetamine to ensure appropriate therapy.

• Amphetamine Thin Layer Chromatography (FDA Code: DIT / 862.3100)

• Barbiturate Enzyme Immunoassay Test (FDA Code: DIS / 862.3150)

A barbiturate test system is a device intended to measure barbiturates, a class of hypnotic and sedative drugs, in serum, urine, and gastric contents. Measurements obtained by this device are used in the diagnosis and treatment of barbiturate use or overdose and in monitoring levels of barbiturate to ensure appropriate therapy.

• Benzodiazepine Enzyme Immunoassay Test (FDA Code: JXM / 862.3170)

A benzodiazepine test system is a device intended to measure any of the benzodiazepine compounds, sedative and hypnotic drugs, in blood, plasma, and urine. The benzodiazepine compounds include chlordiazepoxide, diazepam, oxazepam, chlorzepate, flurazepam, and nitrazepam. Measurements obtained by this device are used in the diagnosis and treatment of benzodiazepine use or overdose and in monitoring levels of benzodiazepines to ensure appropriate therapy.

• Cannabinoids Enzyme Immunoassay Test (FDA Code: LDJ / 862.3870)

A cannabinoid test system is a device intended to measure any of the cannabinoids, hallucinogenic compounds endogenous to marihuana, in serum, plasma, saliva, and urine. Cannabinoid compounds includedelta -9-tetrahydrocannabinol, cannabidiol, cannabinol, and cannabichromene. Measurements obtained by this device are used in the diagnosis and treatment of cannabinoid use or abuse and in monitoring levels of cannabinoids during clinical investigational use.

• Cocaine and Cocaine Metabolites Enzyme Immunoassay Test (FDA Code: DIO / 862.3250)

A cocaine and cocaine metabolite test system is a device intended to measure cocaine and a cocaine metabolite (benzoylecgonine) in serum, plasma, and urine. Measurements obtained by this device are used in the diagnosis and treatment of cocaine use or overdose.

• Cocaine Thin Layer Chromatography Test (FDA Code: DMN / 862.3250)

• Drugs of Abuse Multiple Test Kit (FDA Code: MVO)

• Drugs Of Abuse Test Kits

• Fluorometer for Clinical Use (FDA Code: KHO / 862.2560)

A fluorometer for clinical use is a device intended to measure by fluorescence certain analytes. Fluorescence is the property of certain substances of radiating, when illuminated, a light of a different wavelength. This device is used in conjunction with certain materials to measure a variety of analytes.

• Follicle Stimulating Hormone Radioimmunoassay (FDA Code: CGJ / 862.1300)

A follicle-stimulating hormone test system is a device intended to measure follicle-stimulating hormone (FSH) in plasma, serum, and urine. FSH measurements are used in the diagnosis and treatment of pituitary gland and gonadal disorders.

• HCG Over The Counter Pregnancy Test Kit (FDA Code: LCX / 862.1155)

A human chorionic gonadotropin (HCG) test system is a device intended for the early detection of pregnancy is intended to measure HCG, a placental hormone, in plasma or urine.

• Human Chorionic Gonadotropin Radioimmunoassay (FDA Code: JHI / 862.1155)

• Luteinizing Hormone Radioimmunoassay (FDA Code: CEP / 862.1485)

A luteinizing hormone test system is a device intended to measure luteinizing hormone in serum and urine. Luteinizing hormone measurements are used in the diagnosis and treatment of gonadal dysfunction.

• Metamphetamine Thin Layer Chromatography Test (FDA Code: DJC / 862.3610)

A methamphetamine test system is a device intended to measure methamphetamine, a central nervous system stimulating drug, in serum, plasma, and urine. Measurements obtained by this device are used in the diagnosis and treatment of methamphetamine use or overdose.

• Methadone Enzyme Immunoassay Test (FDA Code: DJR / 862.3620)

A methadone test system is a device intended to measure methadone, an addictive narcotic pain-relieving drug, in serum and urine. Measurements obtained by this device are used in the diagnosis and treatment of methadone use or overdose and to determine compliance with regulations in methadone maintenance treatment.

• Methamphetamine Gas Chromatography Test (FDA Code: LAF / 862.3610)

• Morphine Fluorometry Test (FDA Code: DJJ / 862.3640)

A morphine test system is a device intended to measure morphine, an addictive narcotic pain-relieving drug, and its analogs in serum, urine, and gastric contents. Measurements obtained by this device are used in the diagnosis and treatment of morphine use or overdose and in monitoring levels of morphine and its analogs to ensure appropriate therapy.

• Opiates Enzyme Immunoassay Test (FDA Code: DJG / 862.3650)

An opiate test system is a device intended to measure any of the addictive narcotic pain-relieving opiate drugs in blood, serum, urine, gastric contents, and saliva. An opiate is any natural or synthetic drug that has morphine-like pharmocological actions. The opiates include drugs such as morphine, morphine glucoronide, heroin, codeine, nalorphine, and meperedine. Measurements obtained by this device are used in the diagnosis and treatment of opiate use or overdose and in monitoring the levels of opiate administration to ensure appropriate therapy.

• Phencyclidine Enzyme Immunoassay (FDA Code: LCM)

• Urine Specimen Container for Drugs Of Abuse (FDA Code: MPQ / 864.3260)

An over-the-counter (OTC) test sample collection system for drugs of abuse testing is a device intended to: Collect biological specimens (such as hair, urine, sweat, or saliva), outside of a medical setting and not on order of a health care professional (e.g., in the home, insurance, sports, or workplace setting); maintain the integrity of such specimens during storage and transport in order that the matter contained therein can be tested in a laboratory for the presence of drugs of abuse or their metabolites; and provide access to test results and counseling. This section does not apply to collection, transport, or laboratory testing of biological specimens for the presence of drugs of abuse or their metabolites that is performed to develop evidence for law enforcement purposes.